BSE Live
Oct 01, 16:01Prev. Close
32.41
Open Price
30.62
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Balance Sheet of Emmessar Biotech And Nutrition (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |
Total Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |
Reserves and Surplus | -0.73 | -1.49 | -2.01 | -2.91 | -4.09 | |
Total Reserves and Surplus | -0.73 | -1.49 | -2.01 | -2.91 | -4.09 | |
Total Shareholders Funds | 4.26 | 3.51 | 2.98 | 2.09 | 0.91 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | |
Long Term Provisions | 0.16 | 0.14 | 0.12 | 0.05 | 0.05 | |
Total Non-Current Liabilities | 0.77 | 0.76 | 0.74 | 0.67 | 0.66 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 0.80 | 0.58 | 0.01 | 0.20 | 0.20 | |
Other Current Liabilities | 0.22 | 0.18 | 0.13 | 0.17 | 0.44 | |
Short Term Provisions | 0.08 | 0.07 | 0.06 | 0.09 | 0.06 | |
Total Current Liabilities | 1.10 | 0.90 | 0.19 | 0.46 | 0.70 | |
Total Capital And Liabilities | 6.13 | 5.16 | 3.91 | 3.22 | 2.27 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 1.28 | 1.34 | 1.60 | 0.05 | 0.73 | |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.80 | 0.00 | |
Other Assets | 0.63 | 0.64 | 0.65 | 0.67 | 0.00 | |
Fixed Assets | 1.91 | 1.99 | 2.25 | 1.53 | 0.73 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 0.94 | 0.76 | 0.46 | 0.11 | 0.11 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.01 | 0.17 | |
Other Non-Current Assets | 0.01 | 0.02 | 0.12 | 0.18 | 0.00 | |
Total Non-Current Assets | 2.86 | 2.76 | 2.83 | 1.83 | 1.02 | |
CURRENT ASSETS | ||||||
Current Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Inventories | 1.15 | 0.73 | 0.09 | 0.32 | 0.36 | |
Trade Receivables | 0.03 | 0.04 | 0.03 | 0.04 | 0.36 | |
Cash And Cash Equivalents | 1.88 | 0.71 | 0.27 | 0.32 | 0.43 | |
Short Term Loans And Advances | 0.00 | 0.01 | 0.00 | 0.00 | 0.10 | |
OtherCurrentAssets | 0.20 | 0.91 | 0.68 | 0.70 | 0.00 | |
Total Current Assets | 3.27 | 2.40 | 1.08 | 1.39 | 1.26 | |
Total Assets | 6.13 | 5.16 | 3.91 | 3.22 | 2.27 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 0.40 | 0.30 | 0.26 | 0.60 | 0.30 | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | 0.01 | 0.01 | 0.01 | 0.01 |
19.08.2025
Emmessar Biotec Standalone June 2025 Net Sales at Rs 0.09 crore, up 17.17% Y-o-Y
25.04.2025
Emmessar Biotec Standalone March 2025 Net Sales at Rs 0.10 crore, up 27.09% Y-o-Y
12.02.2025
Emmessar Biotec Standalone December 2024 Net Sales at Rs 0.10 crore, down 70.72% Y-o-Y
08.11.2024
Emmessar Biotec Standalone September 2024 Net Sales at Rs 0.34 crore, up 303.2% Y-o-Y
19.08.2025
Emmessar Biotec Standalone June 2025 Net Sales at Rs 0.09 crore, up 17.17% Y-o-Y
25.04.2025
Emmessar Biotec Standalone March 2025 Net Sales at Rs 0.10 crore, up 27.09% Y-o-Y
12.02.2025
Emmessar Biotec Standalone December 2024 Net Sales at Rs 0.10 crore, down 70.72% Y-o-Y
08.11.2024
Emmessar Biotec Standalone September 2024 Net Sales at Rs 0.34 crore, up 303.2% Y-o-Y
15.03.2018
24.04.2017
24.04.2017
20.04.2017